Peptide receptor radionuclide therapy, also known as PRRT, is an emerging treatment option for neuroendocrine tumours (NETs) in Italy. This novel form of targeted radiotherapy is showing promising results and is being adopted by more oncology facilities across the country.
What is PRRT?
PRRT is a type of systemic radiotherapy where small amounts of radioactive substances are attached to peptides that bind to receptors on cancer cells. The most common peptide used is ... Read more
